Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2024 Feb 1.

Published in final edited form as: J Asthma. 2022 Mar 10;60(2):323–330. doi: 10.1080/02770903.2022.2047718

Table 4:

Summary of Cost Saving Results for Internal and External Models of Transitioning from Nebulized to Metered Dose Inhaler Therapy

Model	N	% Transitionin^{^}	Cost savings	Marginal cost saving^*
Internal	552			$288.20
		50%	$12,136
		80%	$20,738
External	552			$187.50
		50%	$8,927
		80%	$14,283

^*

For every 5 additional patients (~1% of n=552)

^{^}

Transitioning from nebulized therapy to metered dose inhalers after 24 hours